Rethinking definitions of autoimmune disease

Why autoimmune diseases should be redefined by molecular pathway

By Lauren Martz, senior writer

 

The autoimmune field is dialing up its search for better biomarkers as it seeks to make the next step change from the targeted therapiesthat overtook blanket immunosuppressants. The question is whether autoimmunity might follow the lead of oncology and classify indications by molecular drivers rather than the symptoms or tissues involved... (read the full article).

 

From Biocentury Innovations